All FATE Content

Fate Therapeutics, inc (FATE) Q2 2022

Fate Therapeutics, inc (NASDAQ: FATE) Q2 2022 Earnings Conference

August 1, 20221 min read

Fate Therapeutics, inc (FATE) Q1 2022

Fate Therapeutics, inc (NASDAQ: FATE) Q1 2022 Earnings Conference

May 2, 20221 min read

Fate Therapeutics, inc (FATE) Q4 2021 Earnings Call

Fate Therapeutics, inc (NASDAQ: FATE) Q4 2021 Earnings Conference

February 23, 20221 min read

Fate Therapeutics, inc (FATE) Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2021 Financial Results

Fate Therapeutics, inc (NASDAQ: FATE) Q3 2021 Earnings Conference

November 8, 20211 min read

Fate Therapeutics, inc (FATE) Fate Therapeutics to Webcast Conference Call Reporting Second Quarter 2021 Financial Results

Fate Therapeutics, inc (NASDAQ: FATE) Q2 2021 Earnings Conference

July 26, 20211 min read

Analysis

Fate Therapeutics (FATE) looks headed for a turnaround post-COVID

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharma company, has been drawing the market’s attention after reporting positive results from advanced-stage clinical trials on its…

January 26, 20213 min read